ArticlePharmaceutics2022

Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy.

Paula Bachmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.